Advertisement

Topics

AgeX Therapeutics Closes $10 Million Capital Raise

07:00 EDT 17 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
• BioTime saving approximately $5 million annually on programs now in AgeX AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE American: BTX), announced today that it has closed its round of e...

Other Sources for this Article

Media Contact for AgeX:
Gotham Communications, LLC
Bill Douglass, (646) 504-0890
bill@gothamcomm.com
or
Media Contact:
JQA Partners, Inc.
Jules Abraham, (917) 885-7378
jabraham@jqapartners.com
or
Investor Contact for BioTime:
BioTime
David Nakasone, (510) 871-4188
dnakasone@biotimeinc.com
or
EVC Group, Inc.
Michael Polyviou/Doug Sherk, (646) 445-4800
mpolyviou@evcgroup.comdsherk@evcgroup.com

NEXT ARTICLE

More From BioPortfolio on "AgeX Therapeutics Closes $10 Million Capital Raise"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Vascular
Vascular relates to blood vessels (Oxford Medical Dictionary) and can be used to describe the supply of blood, a disease affecting the blood vessels or molecules associated with these structures. For example, <!--LGfEGNT2Lhm-->atherosclerosis ...